Pink Sheet Podcast: House User Fee Bill, Push For OTC Naloxone, SCOTUS Overturning Roe v. Wade

Pink Sheet reporter and editors and HBW Insight editor discuss FDA reforms in the new user fee reauthorization bill, additional industry inducements to market OTC naloxone, and the impact of a Supreme Court’s potential overturning of Roe v. Wade on the agency.